Current Issue

Cover Story

Buyers' Guide 2009

Manufacturers, distributors, consultants and service providers in more than 150 categories.

HomeCareXtra

Cover Story

Sleep On It

Focus on outcomes, education and creative marketing to increase sleep program success.

Marketplace

Somber News

Pittsburgh In the wake of a restructuring that saw a 10-percent reduction in its work force and the closing of a plant, Respironics Inc. warned that earnings for its fiscal 2000 first quarter would likely be only 14 cents per share, 4 cents off analysts' estimates.

Revenues for the quarter ending Sept. 30 were expected to drop 5 percent from the $86.4 million in the same quarter the year before, officials said. James Liken, president and chief executive officer, said the company's recent reorganization "was a significant distraction and did impact our selling efforts during the current quarter."

In addition, officials said, the revenue decrease includes the impact of a change in distribution in Germany. That will not affect company profitability, they said, but will affect sales comparisons for the first quarter by about $2 million.

Liken said cost savings associated with restructuring, expected to be about $10 million annually, should be obvious beginning in the third quarter of fiscal 2000.

After its announcement this summer that its fiscal fourth-quarter earnings had decreased by 69 percent, the company embarked on a restructuring that entailed cutting its work force by 10 percent, closing its Westminster, Colo., manufacturing plant and 19 customer-satisfaction centers, and downsizing its Marietta, Ga., plant. It also opened a centralized distribution and repair center in Youngwood, Pa.

The mid-September news of the earnings revision sent analysts scrambling to revise their performance estimates. ING Barings lowered its quarterly forecast to 14 cents a share from 18 cents, bringing it in line with company predictions. For fiscal 2000, ING Barings lowered its forecast from 92 cents to 88 cents a share.

Meanwhile, Respironics' board of directors authorized the repurchase of an additional 1 million shares of the company's common stock, increasing the total buy-back authorization to 4 million shares. Repurchased shares are added to the company's treasury shares and may be used to meet common stock requirements of employee benefit plans and stock-option plans and for other corporate purposes, officials said. Since the program began in August 1998, the company has repurchased about 2.6 million shares.

Back to Top

Browse previous Issues

December 2008

November 2008

October 2008

September 2008

August 2008

July 2008